These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


399 related items for PubMed ID: 3053901

  • 1. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
    Sampson-Johannes A, Carlino JA.
    J Immunol; 1988 Nov 15; 141(10):3680-6. PubMed ID: 3053901
    [Abstract] [Full Text] [Related]

  • 2. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
    Thomassen MJ, Barna BP, Rankin D, Wiedemann HP, Ahmad M.
    Cancer Res; 1989 Aug 01; 49(15):4086-9. PubMed ID: 2545332
    [Abstract] [Full Text] [Related]

  • 3. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
    Kleinerman ES, Knowles RD, Lachman LB, Gutterman JU.
    Cancer Res; 1988 May 01; 48(9):2604-9. PubMed ID: 3128401
    [Abstract] [Full Text] [Related]

  • 4. Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity.
    Hart PH, Whitty GA, Piccoli DS, Hamilton JA.
    J Immunol; 1988 Sep 01; 141(5):1516-21. PubMed ID: 3137258
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF.
    Wang M, Friedman H, Djeu JY.
    J Immunol; 1989 Jul 15; 143(2):671-7. PubMed ID: 2661688
    [Abstract] [Full Text] [Related]

  • 6. Modulation of human alveolar macrophage tumoricidal activity by recombinant macrophage colony-stimulating factor.
    Thomassen MJ, Barna BP, Wiedemann HP, Ahmad M.
    J Biol Response Mod; 1990 Feb 15; 9(1):87-91. PubMed ID: 2156955
    [Abstract] [Full Text] [Related]

  • 7. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E.
    Hancock WW, Pleau ME, Kobzik L.
    J Immunol; 1988 May 01; 140(9):3021-5. PubMed ID: 3129507
    [Abstract] [Full Text] [Related]

  • 8. Induction of human monocyte susceptibility to lymphokine-activated killer cell lysis by granulocyte-macrophage colony-stimulating factor.
    Blanchard DK, Serbousek D, Djeu JY.
    Cancer Res; 1989 Sep 15; 49(18):5037-43. PubMed ID: 2670200
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity.
    Young DA, Lowe LD, Clark SC.
    J Immunol; 1990 Jul 15; 145(2):607-15. PubMed ID: 2142182
    [Abstract] [Full Text] [Related]

  • 10. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
    Nii A, Fidler IJ.
    Lymphokine Res; 1990 Jul 15; 9(2):113-24. PubMed ID: 2338840
    [Abstract] [Full Text] [Related]

  • 11. Effect of cisplatin treatment of human monocyte cell line U937 on the induction of tumoricidal activity.
    Singh RK, Singh SM, Sodhi A.
    Neoplasma; 1992 Jul 15; 39(3):137-40. PubMed ID: 1528316
    [Abstract] [Full Text] [Related]

  • 12. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
    Chen AR, McKinnon KP, Koren HS.
    J Immunol; 1985 Dec 15; 135(6):3978-87. PubMed ID: 3905966
    [Abstract] [Full Text] [Related]

  • 13. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
    Bundschuh DS, Barsig J, Hartung T, Randow F, Döcke WD, Volk HD, Wendel A.
    J Immunol; 1997 Mar 15; 158(6):2862-71. PubMed ID: 9058823
    [Abstract] [Full Text] [Related]

  • 14. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K, Mihich E, Ehrke MJ.
    Cancer Res; 1989 May 15; 49(10):2606-14. PubMed ID: 2496917
    [Abstract] [Full Text] [Related]

  • 15. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD, Erickson KL.
    Cell Immunol; 1995 Aug 15; 164(1):105-12. PubMed ID: 7634340
    [Abstract] [Full Text] [Related]

  • 16. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.
    Heidenreich S, Gong JH, Schmidt A, Nain M, Gemsa D.
    J Immunol; 1989 Aug 15; 143(4):1198-205. PubMed ID: 2473121
    [Abstract] [Full Text] [Related]

  • 17. Induction of monocyte migration by recombinant macrophage colony-stimulating factor.
    Wang JM, Griffin JD, Rambaldi A, Chen ZG, Mantovani A.
    J Immunol; 1988 Jul 15; 141(2):575-9. PubMed ID: 3290341
    [Abstract] [Full Text] [Related]

  • 18. Human recombinant macrophage colony stimulating factor activates murine Kupffer cells to a cytotoxic state.
    Curley SA, Roh MS, Kleinerman E, Klostergaard J.
    Lymphokine Res; 1990 Jul 15; 9(3):355-63. PubMed ID: 2118971
    [Abstract] [Full Text] [Related]

  • 19. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
    Ziegler-Heitbrock HW, Möller A, Linke RP, Haas JG, Rieber EP, Riethmüller G.
    Cancer Res; 1986 Nov 15; 46(11):5947-52. PubMed ID: 3756932
    [Abstract] [Full Text] [Related]

  • 20. Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity.
    Suzu S, Yokota H, Yamada M, Yanai N, Saito M, Kawashima T, Saito M, Takaku F, Motoyoshi K.
    Cancer Res; 1989 Nov 01; 49(21):5913-7. PubMed ID: 2790805
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.